Allogene Therapeutics Inc. is a biotechnology company developing allogeneic chimeric antigen receptor T cell (CAR-T) therapies for the treatment of cancer, focusing on off-the-shelf solutions for immuno-oncology treatments.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!